pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Sanofi spells out asthma data, AstraZeneca details COPD win at #ERS26

During this year’s European Respiratory Society (ERS) annual meeting in Barcelona, companies such as Sanofi and AstraZeneca lifted the curtain on detailed results from trials they had previously called a success. Upstream Bio and GSK ...

Sep 8, 2026·read at Endpoints ↗

European Respiratory Society annual meeting in Barcelona. (Credit: ERS on Facebook) September 8, 2026 12:24 PM EDT R&DPharma Sanofi spells out asth­ma da­ta, As­traZeneca de­tails COPD win at #ERS26 Ayisha Sharma News Reporter Elizabeth Cairns Senior biopharma journalist Dur­ing this year’s Eu­ro­pean Res­pi­ra­to­ry So­ci­ety (ERS) an­nu­al meet­ing in Barcelona, com­pa­nies such as Sanofi and As­traZeneca lift­ed the cur­tain on de­tailed re­sults from tri­als … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
98 words · retrieved 1m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoExpanding its biopharma plans, Anthropic looks for a life-sciences dealmakerEndpoints
  • 2h agoKrazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12Endpoints
  • 3h agoSandoz unveils plan for biosimilar expansion and new $300M factory in SloveniaEndpoints
  • 3h agoBristol Myers claims Phase 2 success for GPRC5D-directed CAR-TEndpoints
  • 4h agoWhy consumer apps set their sights on patient health recordsEndpoints